Welcome to BioSlice Blog, published by the EU Life Sciences team at Arnold & Porter.
We follow and comment on legal and regulatory developments within the European life sciences community, focusing upon pharmaceuticals, biotech, medical devices and diagnostics. Our aim is to report on key news, as well as provide analyses of topics relevant to the industry, keeping you up-to-date on developments.
The team of life sciences contributors is multidisciplinary, and therefore you can expect to see blog posts related to such topics as life sciences industry regulation, competition, intellectual property, product liability, privacy, transactions, enforcement, and litigation.
We are keen to hear your opinions too, so please join our discussion; we’d love to hear from you: email@example.com.